MiMedx
Develops regenerative biologics and placental tissue allografts for patients.
Company facts
- Founded
- 2008
- Employees
- 837
- Headquarters
- United States
- CEO
- Timothy R Wright
- Type
- Public
- Listed
- NASDAQ: MDXG
- Subsidiaries
- MiMedx Tissue Services, MiMedx Processing Services, MiMedx Supply, MiMedx Japan, SpineMedica
About
MIMEDX is a global leader in placenta-derived biomaterials, offering a comprehensive portfolio of products that support wound care, burn treatment, and surgical applications. With more than a decade of experience, the company partners with clinicians to address chronic and hard-to-heal wounds, delivering solutions that accelerate tissue regeneration and improve patient outcomes. MIMEDX’s expertise extends into orthopedics, spine, and sports medicine, where its innovative products enhance recovery and functional performance. Committed to relentless innovation, the company aims to restore quality of life and set new standards in healing technology worldwide.